206 studies found for:    nash
Show Display Options
Rank Status Study
21 Completed
Has Results
Treating Nonalcoholic Steatohepatitis (NASH) With Metformin
Condition: Hepatitis
Intervention: Drug: Metformin
22 Recruiting Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity
Condition: Obesity
Intervention: Drug: Metformin
23 Terminated Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH
Condition: NASH (Non-alcoholic Steato-hepatitis)
Interventions: Drug: Rosiglitazone;   Drug: alpha-lipoic acid;   Drug: Rosiglitazone/alpha-lipoic acid
24 Completed Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Fatty Liver Disease
Intervention: Drug: Exenatide
25 Unknown  Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis;   Nonalcoholic Fatty Liver Disease
Interventions: Drug: avandia;   Drug: metformin;   Drug: losartan
26 Completed Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease
Conditions: Metabolic Syndrome;   Non Alcoholic Fatty Liver Disease;   Insulin Resistance
Interventions: Dietary Supplement: glucomannan;   Behavioral: lifestyle intervention
27 Completed Role of Exenatide in NASH-a Pilot Study
Conditions: Nonalcoholic Fatty Liver Disease;   (NAFLD)
Intervention: Drug: Exenatide
28 Completed Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: Pioglitazone;   Drug: Placebo
29 Completed Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
Conditions: Nonalcoholic Steatohepatitis;   Fatty Liver Disease
Intervention: Dietary Supplement: Bovine colostrum powder
30 Active, not recruiting Evaluation of an Acellular Osteochondral Graft for Cartilage LEsions Pilot Trial
Condition: Articular Cartilage Injury
Interventions: Device: Kensey Nash Corp. Cartilage Repair Device;   Procedure: Microfracture
31 Enrolling by invitation Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis
Condition: •Non-alcoholic Steatohepatitis (NASH)
Interventions: Drug: Ezetimibe;   Behavioral: Lifestyle
32 Completed Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)
Condition: Fatty Liver Disease, Nonalcoholic
Intervention: Drug: metreleptin
33 Recruiting Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Other: Omega-3 capsules-Fish Oil
34 Completed A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH)
Condition: Fatty Liver
Intervention: Drug: IdB 1016 (Siliphos)
35 Completed Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
Conditions: Fatty Liver;   Hepatitis
Interventions: Drug: Orlistat (Xenical);   Behavioral: 1400 kcal diet (30% fat)
36 Completed Polyunsaturated Fatty Acids (PUFA) in the Treatment of Non-Alcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes Mellitus (PUFA)
Condition: Fatty Liver
Interventions: Drug: PUFA (Opti-EPA);   Drug: Placebo
37 Completed Weight Management in Nonalcoholic Steatohepatitis
Condition: Fatty Liver
Intervention: Behavioral: Weight Management (diet, exercise, and behavior modification)
38 Completed Intragastric Balloon for Treatment of Non Alcoholic Steatohepatitis (NASH)
Condition: Non Alcoholic Steatohepatitis
Interventions: Procedure: AHA diet plus exercise with BIB placement;   Procedure: AHA diet plus exercise with sham BIB placement
39 Recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin
40 Completed Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
Condition: Steatohepatitis
Interventions: Drug: Placebo;   Drug: EPA-E

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years